Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...

Development and evaluation of 5FUCore, OxaliCore, and IrinoCore transcriptomic signatures for predicting response to individual drugs in the FOLFIRINOX regimen: Towards toxicity reduction and ...

PD as best response Worse PFS CR/PR as best response Improved PFS ...

Association of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of 177 Lu-PSMA-617.

The majority of Annual Meeting abstracts will be released at 5:00 PM (ET) on Thursday, May 22, 2025. Late-Breaking Abstracts (LBAs) will be released at 7:00 AM (CT) on the day of scientific ...

The First Author must comply with the following submission policies. The First Author is responsible for communicating policies to all involved parties. The procedure for submission of abstracts that ...

The 2025 ASCO Annual Meeting is The Place to Be—a global gathering where oncology professionals connect, collaborate, and inspire. Known for advancing the field, this must-attend event offers an ...

For reference, please review the following policies and guidelines. As you prepare your submission to the Meeting, please make note of the following author and sponsorship eligibility criteria: ...

Learn more about abstract submission, policies, and guidelines for faculty and presenters.

ASCO recognizes the importance of bringing together researchers to discuss ongoing trials. Trials in Progress posters provide an opportunity for members of the research community to present ongoing ...

Abstracts of superior quality have been selected by the ASCO Scientific Program Committee for presentation at the 2025 ASCO Annual Meeting and for publication in the 2025 ASCO Annual Meeting ...